The Pharmagellan Guide to Biotech Forecasting and Valuation - Paperback
The Pharmagellan Guide to Biotech Forecasting and Valuation - Paperback
About this item
by Frank S. David (Author), Seth Robey (Author), Andrew Matthews (Author)
If you're a biotech executive, investor, deal maker, entrepreneur, or adviser--or aspire to be one--then you need to know how to build and analyze forecasts and valuation models of R&D-stage drugs.
THE PHARMAGELLAN GUIDE TO BIOTECH FORECASTING AND VALUATION is a comprehensive, thoroughly referenced handbook to creating and interpreting financial models for early-stage biopharma assets and companies.
- Vetted benchmarks for key drivers of income, expenses, and valuation.
- Proprietary analyses by Pharmagellan's experienced consulting team.
- More than 150 current references from peer-reviewed research, industry white papers, and SEC filings.
Whether you're making investment decisions, pitching to potential partners or funders, or assessing your own R&D program, this is the one-stop guide you need by your side.
Curated additions for your library
The Art of Decision Making: How to make effective decisions under pressure - Paperback
The Triple Play of Business: A Strategy for a Healthy Company - Paperback
7 Secrets to Success: 7 Specific Strategies I Used to Overcome 5 Years of Failure in Direct Selling - Paperback
Skip the Flip: Secrets the 1% Know About Real Estate Investing - Paperback
